Investment company D1 Capital Partners led a $100m Series B round in Avail Medsystems, the medical technology company pioneering telemedicine for the procedure room, with participation from 8VC and existing investors. "We are very excited to be a part of Avail’s mission to provide universal access to clinical and procedural expertise. Now more than ever, the medical community needs innovative technological solutions to pressing systemic problems. Avail Medsystems is disrupting the industry for the better. We look forward to helping Avail bring Procedural TelemedicineTM to every hospital and surgery center in the US and abroad," James Rogers, D1 Capital Analyst.